glp 1 appointment Virtual shared medical appointments for obesity and GLP-1 medications: A scalable method for optimizing care delivery Ready to get started on

3 Works cited FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, accessed February 2, 2026, Semaglutide Shortage Resolved McDermott Will & Schulte, accessed February 2, 2026, GLP-1 Update: Court Backs FDA in Tirzepatide Compounding Case, accessed February 2, 2026, The Return of 503B Compounding of GLP-1 Medications Frier Levitt, accessed February 2, 2026, The Strategic Imperative of Pharmaceutical Competitor Analysis: A Comprehensive Guide for 2026 and Beyond DrugPatentWatch, accessed February 2, 2026, Maximizing ROI on Drug Development by Monitoring Competitive Patent Portfolios, accessed February 2, 2026, Compounded Drug Products That Are Essentially Copies of Approved Drug Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act FDA, accessed February 2, 2026, GLP-1 Weight-Loss Drugs Off Shortage List

Gastric emptying changes One of the fastest observable effects of GLP-1 therapy is delayed gastric emptying

Compounded semaglutide is prepared by licensed compounding pharmacies under different regulatory frameworks

Watch the Sugar: High blood sugar (hyperglycemia) itself can cause intense thirst

Unopened GLP-1 medications stored properly in the refrigerator at 36F to 46F (2C to 8C) remain effective until the expiration date printed on the packaging